India Extends Covishield Vaccine’s Shelf Life From 6 To 9 Months

Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand.

31 March 2021
Follow Outlook India On News
Representational image.
AP/PTI Photo
India Extends Covishield Vaccine’s Shelf Life From 6 To 9 Months
outlookindia.com
2021-03-31T11:50:11+05:30
Also read

The Drugs Controller General of India (DCGI) has extended the shelf life of Covishield, from six to nine months from its manufacturing date.

The Covishield vaccine has been manufactured by Oxford University in collaboration with multinational pharmaceutical company AstraZeneca.

In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand.

Shelf life is the length of time for which an item remains fit for use.

The DCGI said it has no objection in respect of 'Extension of Shelf Life of Covishield Vaccine' in multi-dose glass vial (10 dose-5ml) from six months to nine months.

"You are permitted to apply the shelf life of nine months to unlabelled vials available on hand, subject to the condition that the details of such stock, batch-wise, shall be submitted to this office and Central Drugs Laboratory, Kasauli," Somani said in the letter.


For in-depth, objective and more importantly balanced journalism, Click here to subscribe to Outlook Magazine

Subscribe to Outlook’s Newsletter

Next Story >>

India Among Fastest Growing Markets For Crop Protection Chemicals: Study

Read More in:

More From Outlook Magazine

More from Website

More from Blog